Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $9,400/year · Income ≤500% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
M05.0 M05.1 M05.2 M05.3 M05.4 M05.5 M05.6 M05.7 M05.79 M05.8 M05.9 M06.0 M06.8 M06.9Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 866-316-7263, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Actemra / biosimilars, Orencia, Remicade / biosimilars, Simponi Aria.
Status shown as of each fund's last verification.
As of May 2, 2026, the PAN Foundation Rheumatoid Arthritis fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 866-316-7263.
Up to $9,400/year. Covers drug cost only — administration billed separately
Household income must be ≤500% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.